Governor General to travel to France to attend the service for former French President Jacques Chirac
OTTAWA, Sept. 29, 2019 /CNW/ - The Prime Minister, Justin Trudeau, today announced that Her Excellency, the Right Honourable Julie Payette, Governor General of Canada, will travel to Paris, France where she will lead a delegation and serve as Canada's official representative at the service for former French President Jacques Chirac. The service will take place on September 30, 2019.
Quote "Former President Jacques Chirac was a great statesman who served the people of France with distinction over the course of his extensive political career. I offer my sincere condolences to his family and friends, and to the French people. On behalf of all Canadians, Her Excellency will pay respects to this great leader." ?The Rt. Hon. Justin Trudeau, Prime Minister of Canada
Quick Facts
Jacques Chirac was the President of France from 1995 to 2007.
Former Prime Minister of Canada, the Right Honourable Jean Chrétien, and Ambassador of Canada to France, Isabelle Hudon, will be in attendance as members of the delegation.
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...
